European Medicines Agency Human Scientific Committees' Working Parties with Patients' and Consumers' Organisations (PCWP) and Healthcare Professionals' Organisations (HCPWP) joint meeting - Workshop on benefit-risk communication

• Date:
  Trešdiena, 17 Septembris 2014, Visu dienu
• Vieta:
  European Medicines Agency, Amsterdam, the Netherlands

This is a joint Workshop with representatives from patients', consumers' and healthcare professionals' organisations. The workshop will provide an overview of how EMA communicates on the benefits and risks of medicines within the EU regulatory network. It will also discuss the role of communication in achieving effectiveness of risk minimisation measures and explore how such communication can support healthcare professionals and patients on their treatment decisions. Registration by invitation only.

Documents

Agenda - European Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting Workshop on benefit-ris...

Reference Number: EMA/254724/2014

List of participants - European Medicines Agency Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting - Worksho...

Reference Number: EMA/348114/2014

Workshop summary - Benefit-risk communication to medicines users: How can regulators best meet the information needs of patients and healthcare professionals?

Reference Number: EMA/755448/2014

Workshop report - Benefit-risk communication to medicines users: How can regulators best meet the information needs of patients and healthcare professionals?

Reference Number: EMA/581546/2014

Presentation - Objectives of the workshop (Isabelle Moulon)

Presentation - Helping doctors and patients make sense of health statistics (Wolfgang Gaissmaier)

Presentation - Communicating benefits and risks of medicines within the European Union regulatory network (Juan Garcia Burgos)

Presentation - Risk-benefit communication: managing media channels (Monika Benstetter)

Presentation - Public impact of communication (Frederic Bouder)

Presentation - Vaccine acceptance or refusal? Individual choice vs societal needs or my risks vs 'our' risks (Heidi Larson)

Presentation - Evidence-based guidance for risk communication planning (Priya Bahri)

Presentation - Benefit-risk communication: perspective from PRAC (June Raine)

Presentation - Strengthening collaborations for operating pharmacovigilance in Europe (Dolores Montero)

Presentation - Looking forward: better communications for better healthcare decisions (Monika Benstetter, Juan Garcia Burgos)

Multimedia